Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity

by Algazi, A., Browning, E., Canton, D.A, Daud, A., Fisher, D., Gujar, R., Han, M., Hermiz, R., Lee, J.Y, Lyerly, H.K, Mukhopadhyay, A., Nguyen, B., Salazar, J., Skitzki, J., Svenson, L., Twitty, C.G, Zhang, J.
Published 2022